Poseida Therapeutics, Inc.

Bank of New York Mellon Corp

Report date

12/31/2024

Quarter

2024 Q4

Filed

2/4/2025

Shares

201,957

Value ($000)

1,939

Weight

0.0%

2020 Q3 - 2024 Q4 (18 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q4	2/4/2025	1,939	0.0%	201,957	12/31/2024
2024 Q3	11/12/2024	469	0.0%	164,101	9/30/2024
2024 Q2	7/25/2024	668	0.0%	228,700	6/30/2024
2024 Q1	4/25/2024	646	0.0%	202,384	3/31/2024
2023 Q4	1/29/2024	773	0.0%	229,960	12/31/2023
2023 Q3	10/24/2023	503	0.0%	211,297	9/30/2023
2023 Q2	8/3/2023	373	0.0%	211,733	6/30/2023
2023 Q1	5/9/2023	150	0.0%	48,783	3/31/2023
2022 Q4	2/14/2023	259	0.0%	48,783	12/31/2022
2022 Q3	11/14/2022	175	0.0%	49,468	9/30/2022
2022 Q2	8/15/2022	45	0.0%	17,558	6/30/2022
2022 Q1	5/11/2022	457	0.0%	102,049	3/31/2022
2021 Q4	2/11/2022	707	0.0%	103,839	12/31/2021
2021 Q3	11/18/2021	739	0.0%	101,388	9/30/2021
2021 Q2	8/11/2021	830	0.0%	82,900	6/30/2021
2021 Q1	5/13/2021	603	0.0%	63,100	3/31/2021
2020 Q4	2/9/2021	324	0.0%	29,581	12/31/2020
2020 Q3	11/12/2020	206	0.0%	23,292	9/30/2020